Filing
1st Quarter - Report
Bills named in this filing
1
Lobbying activity
2
Issues related to drug development and pricing, generally vaccine safety and access, generally the 340B program, Issues related to pharmacy benefit managers, generally. H.R. 5509, the Safe Step Act
Direct-to-Patient Prescription Drug Purchase Platforms Most Favored Nation drug pricing 340B HHS Pilot Program Model